Günter Carl Hober
Managing Partner
+49 (89) 809 53 63- 0
Curriculum vitae & references Quickcontact
The M&A process is a complex procedure requiring multidisciplinary expertise, especially when dealing with companies in the healthcare industry. Professional industry knowledge of regulations, technologies, applications, therapies, products, medical services, and regulations, as well as an extensive healthcare-specific network, are essential.
In the context of mergers and acquisitions ConAlliance offers comprehensive professional M&A advisory services:
Clients that are contemplating the sale of their entire companies, parts of it or certain assets benefit from ConAlliance's experience in divestitures, which includes sales and auctions. As appropriate, we may also advise regarding financial and strategic alternatives to a sale, such as recapitalizations, spin-offs, carve-outs, split-offs or tracking stocks....
ConAlliance advises acquisitions as a means in a company’s current and future growth strategy. In supporting our clients, ConAlliance can help in different aspects of the acquisition process, as for example introductions, collection of information, evaluation of targets, due diligences, bid strategy, negotiation and more specifically with the global coordination of the transaction. Moreover we advise on synergy assessments information and project memoranda, post-merger integration services and financial analysis and structuring
A management buyout (MBO) is a method of acquisition where a company's existing executives acquire a large part or the whole company, Whereas a management buy-in (MBI) happens when an executive or a management team from outside the company buys it, and becomes the new administration. A leveraged buyout (LBO) is when a company is purchased - most often by a financial investor - with significant amounts of borrowed money in order to lever returns-on-investment. ConAlliance offers comprehensive transaction consulting, structuring of the acquisition, search for additional investors, negotiations,
There are forms of cooperation, which lie between M&A and organic growth, as for example strategic alliances and joint ventures. M&A, joint venture and strategic alliance are firm's external development strategies. ConAlliance compares M&A activities with cooperation activities based on the transaction cost theory and resource-based theory in order to ensure the best possible success rate of the deal. In healthcare trademark and brand licensing are very common. A licensor may grant permission to a licensee to distribute products under a trademark ....
ConAlliance also advise companies, investors and creditors in turnaround, distressed and bankruptcy situations. Our distressed mergers and acquisitions services involve asset sales, a change of control or other consulting services, often in contested or litigious settings, which require quick activities
Special situations in mergers and acquisitions include complex cases, such as a public take-over, corporate takeover defense, squeeze-outs, debt and equity restructuring, recapitalisations.
A "succession plan" refers to the process of planning and implementing the transition of leadership or ownership rights in a company from one person or group to another. This process is particularly relevant in family businesses but is also significant in other corporate structures. A successful succession plan ensures that the company remains stable and successful even after the departure of the current owner or manager.
ConAlliance offers comprehensive advice and support in all phases of the transaction process within the context of succession planning. This includes the identification of the successor, preparation of the successor, legal, commercial, and financial planning (excluding legal advice), due diligence, negotiations such as terms and the purchase agreement, communication and change management, and continuity planning.
The sale of patents and technologies plays a crucial role in the healthcare industry, as it enables companies to monetize their investments in research and development and enhance their innovative capacity. Examples such as the acquisition of licensing fees for pharmaceuticals or medical technologies, and the increasing importance of IP rights in digital healthcare, highlight the strategic significance of these transactions.
More Information on the topic of "Patent and Technology sales (intellectual property)"
Acquisition target screening is an essential component of mergers and acquisitions (M&A), where potential takeover candidates are systematically identified and evaluated. This process involves several steps and is of central importance, as it ensures that only the most promising and strategically suitable companies are shortlisted for acquisition. This minimizes risks and maximizes the potential value of the acquisition for the acquiring company.
More Information on the topic of "Acquisition Target Screening"
ConAlliance is one of the world's leading advisors for corporate sales, mergers, and acquisitions in the healthcare industry. We are regularly involved in mid-sized and large transactions, often across national borders.
ConAlliance is one of the world's leading advisors on mergers and acquisitions for the healthcare industry. We are regularly involved in mid-sized and large transactions, often across national borders.
As an independent M&A advisory firm, we represent only the interests of our clients. We provide our clients with competent M&A advisory services in transaction preparation, valuation analyses (business valuation including real estate appraisal), evaluating and proposing financial and strategic alternatives, and negotiation with interested parties, co-shareholders, the works council, or banks, for both the sale and purchase of healthcare companies.
If you are interested in a detailed description of the M&A process and our specific approach, we would be happy to to inform you on our service portfolio as an M&A advisory firm upon request.
Please contact us to receive further information.
ConAlliance healthcare M&A services comprise:
Our global Healthcare Mergers & Acquisitions Team provides direct access to sector-specific expertise, as well as global buyers and sellers, both within your home territory and throughout the world. ConAlliance is one of the most active healthcare M&A advisors.
Our investment banking teams service clients in the healthcare field, as well as related fields such as biotechnology, life sciences, medical technology and pharmaceuticals. Our healthcare investment banking offers clients a broad range of products and services, including mergers and acquisitions, public and private equity, syndicated loans, high-grade debt and high-yield debt.
Contact ConAlliance M&A Advisors, when you are planning to
Our healthcare clients, both large and small, receive the highest quality advice and individual, senior-level attention they deserve. ConAlliance combines deep industry knowledge and global expertise to identify M&A opportunities across the healthcare spectrum.